Antispasmodic Effect of Asperidine B, a Pyrrolidine Derivative, through Inhibition of L-Type Ca2+ Channel in Rat Ileal Smooth Muscle
Open Access
- 9 September 2021
- Vol. 26 (18) , 5492
Abstract
Antispasmodic agents are used for modulating gastrointestinal motility. Several compounds isolated from terrestrial plants have antispasmodic properties. This study aimed to explore the inhibitory effect of the pyrrolidine derivative, asperidine B, isolated from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178, on spasmodic activity. Isolated rat ileum was set up in an organ bath. The contractile responses of asperidine B (0.3 to 30 µM) on potassium chloride and acetylcholine-induced contractions were recorded. To investigate its antispasmodic mechanism, CaCl2, acetylcholine, Nω-nitro-l-arginine methyl ester (l-NAME), nifedipine, methylene blue and tetraethylammonium chloride (TEA) were tested in the absence or in the presence of asperidine B. Cumulative concentrations of asperidine B reduced the ileal contraction by ~37%. The calcium chloride and acetylcholine-induced ileal contraction was suppressed by asperidine B. The effects of asperidine B combined with nifedipine, atropine or TEA were similar to those treated with nifedipine, atropine or TEA, respectively. In contrast, in the presence of l-NAME and methylene blue, the antispasmodic effect of asperidine B was unaltered. These results suggest that the antispasmodic property of asperidine B is probably due to the blockage of the L-type Ca2+ channel and is associated with K+ channels and muscarinic receptor, possibly by affecting non-selective cation channels and/or releasing intracellular calcium.Keywords
Funding Information
- Unit of Excellence in Research and Product Development of Coffee, University of Phayao (UoE64002)
- The NSTDA Chair Professor Grant (the Fourth Grant) of the Crown Property Bureau and the Na-tional Science and Technology Development Agency (The Fourth Grant)
This publication has 25 references indexed in Scilit:
- High K+-induced contraction requires depolarization-induced Ca2+ release from internal stores in rat gut smooth muscleActa Pharmacologica Sinica, 2009
- Tolperisone: A Typical Representative of a Class of Centrally Acting Muscle Relaxants with Less Sedative Side EffectsCNS Neuroscience & Therapeutics, 2008
- Regulation of smooth muscle excitation and contractionNeurogastroenterology & Motility, 2008
- Gastrointestinal Motility Disorders: An UpdateDigestive Diseases, 2006
- NEW INSIGHTS INTO β‐ADRENOCEPTORS IN SMOOTH MUSCLE: DISTRIBUTION OF RECEPTOR SUBTYPES and MOLECULAR MECHANISMS TRIGGERING MUSCLE RELAXATIONClinical and Experimental Pharmacology and Physiology, 2005
- Receptor signaling mechanisms underlying muscarinic agonist‐evoked contraction in guinea‐pig ileal longitudinal smooth muscleBritish Journal of Pharmacology, 2003
- The intracellular pathway of the acetylcholine‐induced contraction in cat detrusor muscle cellsBritish Journal of Pharmacology, 2002
- The reactivity of serotonin, acetylcholine and kcl-induced contractions to relaxant agents in the rat gastric fundusPharmacological Research, 2002
- Guanylate cyclase and the ⋅NO/cGMP signaling pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999
- Differential Regulation of Phospholipase A2(PLA2)-dependent Ca2+ Signaling in Smooth Muscle by cAMP- and cGMP-dependent Protein KinasesJournal of Biological Chemistry, 1998